William Enright, President and CEO at Altimmune, Inc. (ALT), bought 1,300 shares at $0.51 ($663) on 2018-05-25, disclosed to the SEC on 2018-05-29.
Open-market purchase of $663 ALT by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Ticker | Type | Filed | Value | 7d Stock | Filing |
|---|---|---|---|---|---|
| BFRG,BFRGW | BUY | 2023-06-15 | $20K | — | Filing → |
| VACC | SELL | 2023-03-29 | $36K | — |
| Filing → |